AlzeCure Hunts For Small Molecules In Its Alzheimer’s Quest

Swedish Biotech Is Developing Broad CNS portfolio

 
• By Sten Stovall
  
Emerging Company Profile: AlzeCure
CEO says potential small-molecule therapies could offer big advantages over biologics • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D